Related Experiment Video

Updated: Jun 15, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Cethromycin: a promising new ketolide antibiotic for respiratory infections

Sally Rafie1, Conan MacDougall, Charles L James

  • 1Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California, USA.

Pharmacotherapy
|February 26, 2010
PubMed

Insights

Cethromycin, a novel ketolide antibiotic, shows potent activity against respiratory pathogens. It offers promising efficacy and safety for community-acquired pneumonia, potentially overcoming antimicrobial resistance.

Area of Science:

  • Pharmacology and Infectious Diseases
  • Antimicrobial Resistance
  • Respiratory Tract Infections

Background:

  • Community-acquired pneumonia is a leading infectious cause of death in the U.S.
  • Rising antimicrobial resistance threatens the effectiveness of current treatments.
  • Novel antibiotics are urgently needed to combat resistant respiratory pathogens.

Purpose of the Study:

  • To review the pharmacology, in vitro activity, pharmacokinetics, efficacy, and safety of cethromycin.
  • To assess cethromycin's potential as an alternative therapy for respiratory tract infections.
  • To evaluate cethromycin in the context of current antimicrobial resistance challenges.

Main Methods:

  • MEDLINE search (1990-May 2009) for English-language articles on cethromycin (ABT-773).
  • Inclusion of published trials and available poster data.
  • Review of pharmacology, in vitro susceptibilities, pharmacokinetics, efficacy, safety, and drug interactions.

Main Results:

  • Cethromycin demonstrated more potent in vitro antibacterial effects than telithromycin.
  • Exhibited potent inhibition against both gram-positive and gram-negative respiratory pathogens.
  • Clinical trial data support cethromycin's efficacy in treating respiratory tract infections.

Conclusions:

  • Cethromycin shows promise as an alternative to standard therapy for community-acquired pneumonia.
  • Its safety profile, particularly regarding hepatotoxicity, requires further evaluation.
  • Cethromycin may offer more reliable coverage against common respiratory pathogens than traditional agents due to current resistance levels.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli07:35

Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli

Published on: August 3, 2017

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...